Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1361–1380 of 17,529 recalls

February 6, 2024· Today The World

Recalled Item: SCHWINNNG Herbal Dietary Supplement

The Issue: Undeclared Nortadalafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
February 6, 2024· Today The World

Recalled Item: Sustain Herbal Dietary Supplement

The Issue: Undeclared Tadalafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
February 5, 2024· Super Chill Products

Recalled Item: Neptune's Fix

The Issue: Marketed without an approved NDA/ANDA: Product contains tianeptine,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
February 5, 2024· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Mesalamine Extended-Release Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
February 5, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Voriconazole for Oral Suspension

The Issue: Labeling: Incorrect or Missing Package Insert

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 2, 2024· Bausch Health Companies, Inc.

Recalled Item: Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1

The Issue: Subpotent Drug: Out of specification for assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
February 1, 2024· Integrity Products

Recalled Item: RAM IT

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
February 1, 2024· Integrity Products

Recalled Item: To the Moon Capsules

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
February 1, 2024· Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

Recalled Item: TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid

The Issue: Chemical Contamination; presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardCompleted
Refund
February 1, 2024· NATCO Pharma Limited

Recalled Item: Lansoprazole Delayed-Release Capsules USP

The Issue: CGMP Deviations: Inadequate induction sealing on bottles, capsules

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
February 1, 2024· Amerisource Health Services LLC

Recalled Item: HydrALAZINE Hydrochloride Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
January 30, 2024· Brassica Pharma Pvt Ltd

Recalled Item: Equate Lubricant Eye Ointment (Mineral Oil 42.5%

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 30, 2024· Brassica Pharma Pvt Ltd

Recalled Item: CVS Health Lubricant Eye Ointment (Mineral oil 31.9% Emollient

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 30, 2024· Brassica Pharma Pvt Ltd

Recalled Item: Lubricant PM Ointment (Mineral Oil 42.5% and White Petrolatum 57.3%)

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 30, 2024· Brassica Pharma Pvt Ltd

Recalled Item: Equate Stye Lubricant Eye Ointment (Mineral Oil 31.9%

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 25, 2024· Alpha Aromatics

Recalled Item: Pure Care Foaming Mint Hand Sanitizer 62%

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 25, 2024· Teva Pharmaceuticals USA, Inc

Recalled Item: Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35

The Issue: Discoloration: discolored tablets (shades of blue) mixed in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
January 25, 2024· Teva Pharmaceuticals USA, Inc

Recalled Item: Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic...

The Issue: Discoloration: discolored tablets (shades of blue) mixed in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
January 25, 2024· Amerisource Health Services LLC

Recalled Item: Febuxostat Tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 23, 2024· Baxter Healthcare Corporation

Recalled Item: Norepinephrine Bitartrate in 5% Dextrose Injection

The Issue: Incorrect product concentration on the overwrap label: The

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund